Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3564262

Beta release

Statistics of Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0900
2024-1000